bioplax limited
bioplax limited Company Information
Company Number
05278706
Next Accounts
Sep 2025
Industry
Activities of patent and copyright agents; other legal activities (other than those of barristers and solicitors) n.e.c.
Wholesale of pharmaceutical goods
Directors
Shareholders
esperia servizi fiduciari spa
Group Structure
View All
Contact
Registered Address
endeavour house, 78 stafford road, wallington, SM6 9AY
Website
www.bioplaxpharma.combioplax limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPLAX LIMITED at £0 based on a Turnover of £0 and 0.5x industry multiple (adjusted for size and gross margin).
bioplax limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPLAX LIMITED at £0 based on an EBITDA of £-106k and a 3.88x industry multiple (adjusted for size and gross margin).
bioplax limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPLAX LIMITED at £455.8k based on Net Assets of £254.5k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bioplax Limited Overview
Bioplax Limited is a live company located in wallington, SM6 9AY with a Companies House number of 05278706. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in November 2004, it's largest shareholder is esperia servizi fiduciari spa with a 100% stake. Bioplax Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bioplax Limited Health Check
Pomanda's financial health check has awarded Bioplax Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 2 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Bioplax Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (6.5%)
- - Bioplax Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Bioplax Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Bioplax Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (25)
- Bioplax Limited
- - Industry AVG
Pay Structure
on an average salary of £56.6k, the company has an equivalent pay structure (£56.6k)
- Bioplax Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Bioplax Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Bioplax Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 15829 days, this is slower than average (24 days)
- - Bioplax Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Bioplax Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2701 weeks, this is more cash available to meet short term requirements (18 weeks)
- - Bioplax Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.9%, this is a lower level of debt than the average (52.5%)
- - Bioplax Limited
- - Industry AVG
BIOPLAX LIMITED financials
Bioplax Limited's latest turnover from December 2023 is 0 and the company has net assets of £254.5 thousand. According to their latest financial statements, we estimate that Bioplax Limited has 1 employee and maintains cash reserves of £257.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 609,838 | 1,332,870 | 1,139,613 | 1,635,172 | 2,702,340 | 2,473,625 | 3,033,417 | ||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cost Of Sales | 114 | 122 | 433,667 | 1,028,387 | 916,939 | 1,337,551 | 2,446,915 | 2,302,355 | 2,765,729 | ||||||
| Gross Profit | -114 | -122 | 176,171 | 304,483 | 222,674 | 297,621 | 255,424 | 171,269 | 267,688 | ||||||
| Admin Expenses | 105,915 | 131,023 | 239,887 | 258,342 | 262,133 | 333,839 | 212,508 | 283,344 | 207,130 | ||||||
| Operating Profit | -106,029 | -131,145 | -63,716 | 46,141 | -39,459 | -36,218 | 42,916 | -112,075 | 60,558 | ||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | ||||||
| Pre-Tax Profit | -106,029 | -131,145 | -63,716 | 46,141 | -39,459 | -36,218 | 42,916 | -112,064 | 60,558 | ||||||
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5,895 | ||||||
| Profit After Tax | -106,029 | -131,145 | -63,716 | 46,141 | -39,459 | -36,218 | 42,916 | -112,064 | 54,664 | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Profit | -106,029 | -131,145 | -63,716 | 46,141 | -39,459 | -36,218 | 42,916 | -112,064 | 54,664 | ||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* | -106,029 | -131,145 | -60,461 | 49,454 | -36,223 | -32,850 | 47,461 | -106,016 | 62,440 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 459,334 |
| Intangible Assets | 0 | 0 | 0 | 3,315 | 6,473 | 10,184 | 13,474 | 18,182 | 5,651 | 6,417 | 8,026 | 11,345 | 16,365 | 232,972 | 206,061 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 72,982 | 77,374 | 83,707 | 78,859 | 85,264 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 3,315 | 6,473 | 10,184 | 13,474 | 18,182 | 5,651 | 6,417 | 81,008 | 88,719 | 100,072 | 311,831 | 750,660 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 240,740 | 225,044 | 246,635 | 261,970 | 251,053 | 441,003 | 400,172 | 1,532,238 | 348,501 | 295,387 | 617,502 | 771,415 | 546,186 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 1,910 | 14,818 | 30,701 | 22,915 | 26,060 | 20,031 | 3,478 | 14,839 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 257,514 | 355,512 | 469,471 | 551,842 | 610,629 | 675,362 | 2,347,294 | 3,131,122 | 2,694,140 | 1,470,998 | 532,154 | 840,254 | 982,710 | 661,447 | 731,867 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 259,424 | 370,330 | 740,912 | 799,801 | 883,324 | 957,517 | 2,601,784 | 3,586,964 | 3,094,311 | 3,003,236 | 880,655 | 1,135,641 | 1,600,212 | 1,432,862 | 1,278,053 |
| total assets | 259,424 | 370,330 | 740,912 | 803,117 | 889,797 | 967,701 | 2,615,259 | 3,605,146 | 3,099,962 | 3,009,653 | 961,662 | 1,224,360 | 1,700,284 | 1,744,693 | 2,028,712 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 4,956 | 9,833 | 227,884 | 235,739 | 380,808 | 384,121 | 399,380 | 1,401,910 | 723,741 | 1,043,329 | 388,520 | 781,780 | 1,382,622 | 1,226,536 | 1,375,599 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 19,661 | 0 | 0 | 8,384 | 14,748 | 18,916 | 12,664 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 4,956 | 9,833 | 247,545 | 235,739 | 380,808 | 392,569 | 413,953 | 1,420,827 | 736,406 | 1,043,329 | 388,520 | 781,780 | 1,382,622 | 1,226,536 | 1,375,599 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67,223 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67,223 |
| total liabilities | 4,956 | 9,833 | 247,545 | 235,739 | 380,808 | 392,569 | 413,953 | 1,420,827 | 736,406 | 1,043,329 | 388,520 | 781,780 | 1,382,622 | 1,226,536 | 1,442,822 |
| net assets | 254,468 | 360,497 | 493,366 | 567,378 | 508,990 | 575,132 | 2,201,306 | 2,184,320 | 2,363,556 | 1,966,324 | 573,142 | 442,581 | 317,662 | 518,158 | 585,890 |
| total shareholders funds | 254,468 | 360,497 | 493,366 | 567,378 | 508,990 | 575,132 | 2,201,306 | 2,184,320 | 2,363,556 | 1,966,324 | 573,142 | 442,581 | 317,662 | 518,158 | 585,890 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Nov 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -106,029 | -131,145 | -63,716 | 46,141 | -39,459 | -36,218 | 42,916 | -112,075 | 60,558 | ||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 229,668 |
| Amortisation | 0 | 0 | 3,255 | 3,313 | 3,236 | 3,368 | 4,545 | 6,059 | 1,882 | 2,138 | 2,675 | 3,781 | 230,926 | 0 | 9,590 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5,895 | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -12,908 | -256,622 | 23,481 | -24,736 | -7,311 | 22,459 | -198,295 | 55,671 | -1,132,067 | 1,183,738 | 53,113 | -322,115 | -153,913 | 225,230 | 546,185 |
| Creditors | -4,876 | -218,051 | -7,855 | -145,069 | -3,313 | -15,259 | -1,002,530 | 678,169 | -319,588 | 654,808 | -393,259 | -600,842 | 156,086 | -149,063 | 1,375,599 |
| Accruals and Deferred Income | 0 | -19,661 | 19,661 | 0 | -8,384 | -6,364 | -4,168 | 6,252 | 12,664 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -97,997 | -112,235 | -72,136 | -70,879 | -40,609 | -76,932 | -760,942 | 522,734 | 881,688 | ||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -72,982 | -4,392 | -6,333 | 4,847 | -6,405 | 85,264 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -67,223 | 67,223 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | ||||||
| cash flow from financing | -1 | -1,724 | -10,295 | 12,247 | -26,684 | -1,589,956 | -25,930 | -67,163 | 342,569 | ||||||
| cash and cash equivalents | |||||||||||||||
| cash | -97,998 | -113,959 | -82,371 | -58,787 | -64,732 | -1,671,932 | -783,828 | 436,982 | 1,223,141 | 938,844 | -308,100 | -142,456 | 321,263 | -70,421 | 731,867 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -97,998 | -113,959 | -82,371 | -58,787 | -64,732 | -1,671,932 | -783,828 | 436,982 | 1,223,141 | 938,844 | -308,100 | -142,456 | 321,263 | -70,421 | 731,867 |
bioplax limited Credit Report and Business Information
Bioplax Limited Competitor Analysis
Perform a competitor analysis for bioplax limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mature companies, companies in SM6 area or any other competitors across 12 key performance metrics.
bioplax limited Ownership
BIOPLAX LIMITED group structure
Bioplax Limited has no subsidiary companies.
Ultimate parent company
ESPERIA SERVIZI FIDUCIARI SPA
#0081812
1 parent
BIOPLAX LIMITED
05278706
bioplax limited directors
Bioplax Limited currently has 1 director, Mr Andrea Artioli serving since Sep 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Andrea Artioli | England | 56 years | Sep 2016 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
-106k
-19%
gross margin
null%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
254.5k
-0.29%
total assets
259.4k
-0.3%
cash
257.5k
-0.28%
net assets
Total assets minus all liabilities
Similar Companies
bioplax limited company details
company number
05278706
Type
Private limited with Share Capital
industry
69109 - Activities of patent and copyright agents; other legal activities (other than those of barristers and solicitors) n.e.c.
46460 - Wholesale of pharmaceutical goods
incorporation date
November 2004
age
20
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
PB PARTNERS LLP
auditor
-
address
endeavour house, 78 stafford road, wallington, SM6 9AY
Bank
-
Legal Advisor
-
bioplax limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bioplax limited.
bioplax limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOPLAX LIMITED. This can take several minutes, an email will notify you when this has completed.
bioplax limited Companies House Filings - See Documents
| date | description | view/download |
|---|
